Detalles de la búsqueda
1.
Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
JAMA
; 311(18): 1870-82, 2014 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24825642
2.
A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years.
Gynecol Oncol
; 108(1): 106-11, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17945335
3.
Stereologic estimation of the total numbers, the composition and the anatomic distribution of lymphocytes in cone biopsies from patients with stage I squamous cell carcinoma of the cervix uteri.
APMIS
; 115(12): 1321-30, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18184401
4.
First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12months and 5years of age.
Vaccine
; 35(4): 596-604, 2017 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28027810
5.
Rationale and design of LAPLACE-2: a phase 3, randomized, double-blind, placebo- and ezetimibe-controlled trial evaluating the efficacy and safety of evolocumab in subjects with hypercholesterolemia on background statin therapy.
Clin Cardiol
; 37(4): 195-203, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24481874
Resultados
1 -
5
de 5
1
Próxima >
>>